Akums Drugs and Pharmaceuticals Limited has submitted a regulatory disclosure to the National Stock Exchange of India Ltd. (NSE) and BSE Limited, intimating them of its scheduled participation in an investor/analysts meet.
The disclosure is made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Event Details
- Event Type: Physical Conference titled "India Investor Conference"
- Date of Meeting: 8th June 2026
- Start Time: 09:00 AM IST
- Type of Meet: Group meet
- Location / Mode: Grand Hyatt, Mumbai / Physical
The company explicitly states that no unpublished price sensitive information (UPSI) pertaining to the company will be shared with investors or analysts during this meet.
A note clarifies that the scheduled details are subject to change due to exigencies on the part of the host or the company itself.
A copy of this disclosure has been updated on the company's website at www.akums.in.
The letter is signed by Dharamvir Malik, Company Secretary & Compliance Officer, and is digitally timestamped on June 03, 2026, at 18:20:33 IST.